Cellular cardiac regenerative therapy in which patients?

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Myocardial diseases cause ventricular dysfunction, necessitating regenerative therapies.
• Numerous cell types are being investigated for cardiac repair, including stem cells and progenitor cells.
• Current applications target myocardial infarction and cardiomyopathies, with potential for other heart conditions.

Purpose of the Study:

• To review current cell-based regenerative therapies for myocardial diseases.
• To discuss various cell sources and their suitability for different cardiac conditions.
• To explore future directions, including combination therapies for enhanced cardiac regeneration.

Main Methods:

• Review of experimental and clinical trials on cell-based myocardial regeneration.
• Analysis of different cell types proposed for cardiac therapy.
• Discussion of current and potential clinical indications for stem cell therapy.
• Exploration of advanced strategies like tissue engineering and dynamic cellular support.

Main Results:

• A wide array of cell types show potential for myocardial regeneration.
• Stem cell therapy aims to improve cardiac function in conditions like myocardial infarction and heart failure.
• Regenerative approaches are intended to delay or avoid heart transplantation in selected patients.

Conclusions:

• Cell-based therapy offers a promising avenue for treating myocardial damage.
• Combining cell transplantation with tissue-engineered scaffolds and pacing may create a 'bioartificial myocardium'.
• Further research is needed to optimize cell sources and therapeutic strategies for diverse cardiac conditions.